A major breakthrough in cancer research is emerging with the use of VHH fragments to re-engage dysfunctional p53. This crucial malignant protector protein is frequently inactivated in various forms of tumors, resulting https://highkeysocial.com/story7585670/mini-antibodies-reactivate-the-p53-protein-a-new-approach-for-tumor-management